This supports the notion that ILCs upregulate multiple different co-receptors within the tumor that likely boosts the anti-tumor responses carried out by ILC1s, however without understanding the molecular mechanisms by which these co-receptors regulate ILC function, their expression remains correlative of immunosuppressive tumor microenvironment. The gene discussed is CCL27; the disease is neoplasm.